Arnold Michael R, Wormer Blair A, Kao Angela M, Klima David A, Colavita Paul D, Cosper Graham H, Heniford Brant Todd, Schulman Andrew M
Levine Children's Hospital, Carolinas Healthcare System, 1000 Blythe Blvd., Charlotte, NC, 28203, USA.
Hemby Children's Hospital, Novant Health, 200 Hawthorne Ln., Charlotte, NC, 28204, USA.
Pediatr Surg Int. 2018 Dec;34(12):1257-1268. doi: 10.1007/s00383-018-4343-0. Epub 2018 Sep 14.
To compare the effect of home intravenous (IV) versus oral antibiotic therapy on complication rates and resource utilization following appendectomy for perforated appendicitis.
This was a randomized controlled trial of patients aged 4-17 with surgically treated perforated appendicitis from January 2011 to November 2013. Perforation was defined intraoperatively and divided into three grades: I-contained perforation, II-localized contamination to right gutter/pelvis, and III-diffuse contamination. Patients were randomized to complete a ten-day course of home antibiotic therapy with either IV ertapenem or oral amoxicillin-clavulanate. Thirty-day postoperative complication rates including abscess, readmission, wound infection, and charges were compared.
Eighty-two patients were enrolled. Forty four (54%) were randomized to the IV group and 38 (46%) to the oral group. IV patients were older (12.3 ± 3.6 versus 10.1 ± 3.6, p < 0.05) with higher BMI (20.9 ± 5.8 versus 17.9 ± 3.5, p < 0.05). There were no differences in gender, comorbidities, or perforation grade (I-20.4% vs. 26.3%, II-36.4% vs. 34.2%, III-43.2% vs. 39.5%, all p > 0.05). Comparing IV to oral, there was no difference in length of stay (4.4 ± 1.5 versus 4.4 ± 2.0 days, p > 0.05), postoperative abscess rate (11.6% vs. 8.1%, p > 0.05), or readmission rate (14.0% vs. 16.2%, p > 0.05). Hospital and outpatient charges were higher in the IV group (p < 0.0001).
Oral antibiotics had equivalent outcomes and incurred fewer charges than IV antibiotics following appendectomy for perforated appendicitis.
比较家庭静脉注射(IV)与口服抗生素疗法对穿孔性阑尾炎阑尾切除术后并发症发生率和资源利用情况的影响。
这是一项针对2011年1月至2013年11月期间接受手术治疗的4至17岁穿孔性阑尾炎患者的随机对照试验。穿孔在术中定义,并分为三个等级:I级——局限性穿孔,II级——右结肠旁沟/盆腔局部污染,III级——弥漫性污染。患者被随机分配接受为期十天的家庭抗生素治疗,使用静脉注射厄他培南或口服阿莫西林-克拉维酸盐。比较术后30天的并发症发生率,包括脓肿、再次入院、伤口感染和费用。
共纳入82例患者。44例(54%)被随机分配至静脉注射组,38例(46%)被分配至口服组。静脉注射组患者年龄较大(12.3±3.6岁 vs. 10.1±3.6岁,p<0.05),体重指数较高(20.9±5.8 vs. 17.9±3.5,p<0.05)。性别、合并症或穿孔等级方面无差异(I级——20.4%对2